Background: Anticoagulation monitoring practices vary during extracorporeal membrane oxygenation (ECMO). The Extracorporeal Life Support Organization describes that a multimodal approach is needed to overcome assay limitations and minimize complications.
Objective: Compare activated clotting time (ACT) versus multimodal approach (activated partial thromboplastin time (aPTT)/anti-factor Xa) for unfractionated heparin (UFH) monitoring in adult ECMO patients.
Methods: We conducted a single-center retrospective pre- (ACT) versus post-implementation (multimodal approach) study. The incidence of major bleeding and thrombosis, blood product and antithrombin III (ATIII) administration, and UFH infusion rates were compared.
Results: Incidence of major bleeding (69.2% versus 62.2%, p = 0.345) and thrombosis (23% versus 14.9%, p = 0.369) was similar between groups. Median number of ATIII doses was reduced in the multimodal group (1.0 [IQR 0.0-2.0] versus 0.0 [0.0 -1.0], p = 0.007). The median UFH infusion rate was higher in the ACT group, but not significant (16.9 [IQR 9.6-22.4] versus 13 [IQR 9.6-15.4] units/kg/hr, p = 0.063). Fewer UFH infusion rate changes occurred prior to steady state in the multimodal group (0.9 [IQR 0.3 -1.7] versus 0.1 [IQR 0.0-0.2], p < 0.001).
Conclusion: The incidence of major bleeding and thrombosis was similar between groups. Our multimodal monitoring protocol standardized UFH infusion administration and reduced ATIII administration.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/08971900211021249 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Anticoagulation Monitoring During ECMO Support: Monitor or Flip a Coin?
Clin Cardiol
December 2024
Department of Anaesthesiology and Intensive Care Medicine, Medical University Innsbruck, Innsbruck, Austria.
Should we rely on anticoagulation monitoring in ECMO patients or simply flip a coin? The increasing use of anti-factor Xa activity to monitor the effect of UFH appears appropriate, given its moderate correlation with the UFH infusion rates, and it may play a role in preventing thromboembolic events. However, to avoid bleeding complications, more sophisticated tools, and careful clinical decision-making remain essential.
View Article and Find Full Text PDFEvaluation of unfractionated heparin therapy for venous thromboembolism using adjusted body weight in elderly or higher weight patients.
J Thromb Thrombolysis
December 2024
Cooper University Hospital, One Cooper Plaza, Camden, NJ, 08103, USA.
The use of weight-based unfractionated heparin (UFH) infusions is the standard of care in hospital management of venous thromboembolism (VTE). Initial dosing strategies for UFH in older adults and higher body weight patients remain uncertain given differences in pharmacokinetics and concerns for over-anticoagulation. Methods: This was a single-center, retrospective, pre-post study involving older adults aged ≥ 65 years and patients weighing ≥ 100 kg with suspected or confirmed VTE to determine if the use of adjusted body weight (AdjBW)-based UFH regimens improves time to therapeutic anti-Xa levels compared to total body weight (TBW)-based regimens Patients received weight-based UFH infusions, dosed according to either TBW or AdjBW, to target a therapeutic anti-Xa level.
View Article and Find Full Text PDFRevisiting the Efficacy and Safety of Bivalirudin in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From a Mixed Treatment Comparison Meta-Analysis of Randomized Trials.
Catheter Cardiovasc Interv
January 2025
Division of Cardiovascular Medicine, New York University Grossman School of Medicine, New York, New York, USA.
Background: Randomized trials of bivalirudin in patients with ST elevation myocardial infarction (STEMI) have yielded heterogeneous results.
Aims: Our aim was to evaluate the efficacy and safety of four antithrombin regimens-unfractionated heparin (UFH), bivalirudin (stopped soon after percutaneous coronary intervention [PCI]), extended bivalirudin (continued for a few hours after PCI), and combined UFH and a Gp2b3a inhibitors (GPI) in patients who present with STEMI.
Methods: A PubMed, EMBASE, and clinicaltrials.
Bleeding outcomes in critically ill patients on heparin with discordant aPTT and anti-Xa activity.
J Thromb Thrombolysis
October 2024
Houston Methodist Hospital, Houston, TX, USA.
Activated partial thromboplastin time (aPTT) and unfractionated heparin (UFH) level via the anti-factor Xa activity assay (anti-Xa) are commonly used assays for UFH monitoring. While discordance between the two assays is common, its impact on critically ill patient outcomes is unclear. This study aimed to compare the incidence of major bleeding events among critically ill patients with discordant aPTT and anti-Xa activity while on UFH, to patients with no discordance.
View Article and Find Full Text PDFAnaphylaxis to Protamine During a Carotid Endarterectomy.
Cureus
August 2024
Anesthesiology, University of Miami Miller School of Medicine, Miami, USA.
Article Synopsis
- - Protamine sulfate is used to reverse the effects of unfractionated heparin during surgeries but can cause severe reactions like anaphylaxis.
- - A 77-year-old male experienced serious side effects, including low blood pressure and rapid heart rate, after receiving protamine during a carotid endarterectomy.
- - The case stresses the need for careful monitoring when administering protamine, especially for high-risk patients, and suggests looking into alternative methods for reversal to improve safety.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!